- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Elucidating the mechanism of type 2 innate lymphoid...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Elucidating the mechanism of type 2 innate lymphoid cell-mediated tumour elimination de Lucía Finkel, Pablo
Abstract
Besides amplifying type 2 immune responses, the role of type 2 innate lymphoid cells (ILC2s) in cancer remains ambiguous. While some studies suggest that ILC2s exert immunosuppressive functions, others present evidence they enhance anti-cancer immunity. However, their successful isolation from mammal tissues and in vitro expansion continues to pose challenges. This is partly due to their scarcity compared to other leukocyte populations, but also because our current knowledge on ILC2 biology is incomplete. In this study, we focused on ST2+ IL-25Rlo lung resident ILC2s and demonstrate for the first time how mouse type 2 innate lymphoid cells can be cultured, grown and expanded in serum-free media containing interleukin-33 (IL-33), TSLP, IL-2 and IL-7. Moreover, we report that ILC2s from the lungs of mice with primary tumours are able to cross-present the ovalbumin peptide OVA257-264 and effectively cross-prime a population of OT-I cells. Our data also demonstrates that ILC2s from naïve mice are less efficient at antigen cross-presentation, suggesting a plastic cellular identity in the presence or absence of a tumour. To further our understanding of ILC2s harvested from mice with primary tumours, our single-cell RNA sequencing analyses reveal a highly heterogeneous population with several subsets. One of them downregulates markers associated to type 2 identity such as GATA-3, IL-5 or IL-13, but also begins to express pro-inflammatory markers like granzyme B, IFNγ or interferon-induced membrane proteins. We hypothesize that systemic inflammation or a tumour environment can trigger differentiation of a portion of the lung resident ILC2 population into a pro-inflammatory subset. The existence of these cells challenges current paradigms of ILC2 biology and implies the participation of a distinct agent in the process of cancer immune surveillance.
Item Metadata
Title |
Elucidating the mechanism of type 2 innate lymphoid cell-mediated tumour elimination
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
2020
|
Description |
Besides amplifying type 2 immune responses, the role of type 2 innate lymphoid cells (ILC2s) in cancer remains ambiguous. While some studies suggest that ILC2s exert immunosuppressive functions, others present evidence they enhance anti-cancer immunity. However, their successful isolation from mammal tissues and in vitro expansion continues to pose challenges. This is partly due to their scarcity compared to other leukocyte populations, but also because our current knowledge on ILC2 biology is incomplete. In this study, we focused on ST2+ IL-25Rlo lung resident ILC2s and demonstrate for the first time how mouse type 2 innate lymphoid cells can be cultured, grown and expanded in serum-free media containing interleukin-33 (IL-33), TSLP, IL-2 and IL-7. Moreover, we report that ILC2s from the lungs of mice with primary tumours are able to cross-present the ovalbumin peptide OVA257-264 and effectively cross-prime a population of OT-I cells. Our data also demonstrates that ILC2s from naïve mice are less efficient at antigen cross-presentation, suggesting a plastic cellular identity in the presence or absence of a tumour. To further our understanding of ILC2s harvested from mice with primary tumours, our single-cell RNA sequencing analyses reveal a highly heterogeneous population with several subsets. One of them downregulates markers associated to type 2 identity such as GATA-3, IL-5 or IL-13, but also begins to express pro-inflammatory markers like granzyme B, IFNγ or interferon-induced membrane proteins. We hypothesize that systemic inflammation or a tumour environment can trigger differentiation of a portion of the lung resident ILC2 population into a pro-inflammatory subset. The existence of these cells challenges current paradigms of ILC2 biology and implies the participation of a distinct agent in the process of cancer immune surveillance.
|
Genre | |
Type | |
Language |
eng
|
Date Available |
2020-07-06
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0392343
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
2020-11
|
Campus | |
Scholarly Level |
Graduate
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International